Medication Used to Stop the Production of Breast Milk is Being Recalled

Mother breastfeeding her baby, close-up shot.

A medication, APO-Cabergoline, used by women who just gave birth to assist in drying up breast milk has been recalled because of a packaging issue that may affect the drug.

Apotex Pty Ltd is recalling one batch of the APO-Cabergoline 500mcg tablets,�which can also�be used by women to treat abnormally high levels of prolactin.

The company said that the drying agent on the packaging of these tablets may�not protect the product from moisture throughout its shelf life. It added that failure to protect the tablets�from moisture could�degrade the product over time which may affect its�effectiveness.

Breastfeeding Drug, APO-Cabergoline, Used to Stop the Production of Breast Milk is Being Recalled | Stay at Home Mum

The�batch of the product being recalled�has the number�MK0903, with the expiry date February 2017, which can be found on the bottle label or underneath the carton,

The company urges consumers who purchased the product to return it to the pharmacy where it was bought for a refund or a replacement product,�or contact Apotex Medical Information on 1800 195 055.

Source:�Kidspot.com.au�and Product Safety Australia

author avatar
Clare Whitfield Chief Editor
Clare Whitfield is the Editor of Stay at Home Mum and a recognised voice in practical home management for Australian families. Based in the northern suburbs of Sydney, she balances editorial leadership with life as a stay at home mum to two school age children. Her background in home economics and more than a decade of experience in recipe development, family budgeting, and household systems inform her work.

Discover more from Stay at Home Mum

Subscribe to get the latest posts to your email

Recent comments

Discover more from Stay at Home Mum

Subscribe now to keep reading and get access to the full archive.

Continue reading